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Background: For patients with a major depressive episode, early differential diagnosis of bipolar disorder
and subsequent appropriate treatment are critical. This study, conducted in clinical settings in Japan,
examined patients with a major depressive episode to investigate the prevalence and predictors of
bipolar disorders.
Methods: A total of 448 patients with a major depressive episode were interviewed using the Mini-
International Neuropsychiatric Interview to determine the presence of mood episodes and psychiatric
comorbidities. The diagnosis of bipolar disorder was based on the collected information according to the
DSM-IV-TR.
Results: Of the 448 patients with a major depressive episode, 114 patients (25.4%) were diagnosed with
bipolar disorder. Multivariate logistic regression identiﬁed ﬁve predictors that were signiﬁcantly
correlated with bipolar disorder: antidepressant-related switch to mania/hypomania, mixed depression,
two or more previous mood episodes within the past year, early age at the onset of a major depressive
episode (o25 years), and a history of suicide attempts. The area under the curve of receiver operating
characteristic analysis based on the multivariate logistic regression of the ﬁve predictors was 0.849.
Limitations: The diagnosis of bipolar disorder in patients was already conclusively conﬁrmed by long
illness observations but was not conﬁrmed by a prospective study.
Conclusions: In patients with a major depressive episode, the differential diagnosis of bipolar disorder
and major depressive disorder, which exhibit similar depressive symptoms, is essential. Several
predictors identiﬁed in the present study may be useful in supporting a differential diagnosis of these
disorders in routine clinical practice.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Bipolar disorder (BD) is a chronic disease characterized by
repeated manic and depressive episodes alternating over a long
period of time after disease onset with an extremely high risk of
relapse and recurrence (Kanba et al., 2013; Keller et al., 1993). It is
further known that many patients with BD have more prolonged
depressive episodes than manic episodes during the illness (Judd
et al., 2002; Judd et al., 2003). In an approximate 13-year pros-
pective follow-up of patients with BD, the depressive episode
duration was approximately 3 times (bipolar I disorder (BD-I)) to
40 times (bipolar II disorder (BD-II)) longer than the manic
episode duration (Judd et al., 2002; Judd et al., 2003). The majority
of patients with BD visit psychiatrists during depressive episodes,
which may reﬂect their greater self-awareness of depression com-
pared with their awareness of experiencing mania/hypomania
(Dell'Osso et al., 2002).
Differentiating in the clinical setting between bipolar depres-
sion and major depressive disorder (MDD) in patients with a major
depressive episode (MDE) is critical because patients with BD who
present with an MDE are likely to be diagnosed with MDD. This
occurs because depressive episodes exist with both disorders (BD
and MDD), and patients and physicians may not be aware of prior
or future episodes of mania/hypomania (Hirschfeld et al., 2003). In
a previous study, 20.8% of patients being treated for MDD were
diagnosed with BD after administering the Mini-International
Neuropsychiatric Interview (M.I.N.I.) (Xiang et al., 2013). The onset
episode in two-thirds of the patients with BD is a depressive
episode (Daban et al., 2006), and unipolar-to-bipolar conversion in
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most BD patients with depressive onset occurs within 5–9 years
(Akiskal et al., 1995) or on the average 6.4 years after onset of ﬁrst
depression (Akiskal et al., 1983). For these reasons, more than half of
the patients with BD are initially diagnosed with MDD until a mania/
hypomania episode, which can occur several years after onset. Hence,
patients with an MDE being treated for MDD can actually suffer from
BD, but they are not clinically diagnosed as such.
Diagnosing a patient with unrecognized BD as MDD is detrimental
to the subsequent course and outcome of the disease, and therefore, it
is an issue that must be addressed in the treatment of BD. Patients
with BD who are diagnosed as having a MDD will be treated prima-
rily with antidepressants. However, major treatment guidelines for
mood disorders recommend mood stabilizers and antipsychotics as
ﬁrst-line drugs for the treatment of depression due to BD, rather than
antidepressant monotherapy (Kanba et al., 2013; Yatham et al., 2013).
Accordingly, no appropriate treatment is provided for unrecognized
bipolar depression during this interim period, and the delay of
appropriate treatment may result in prolongation of the disease or a
signiﬁcant increase in the incidence of suicide attempts (Altamura
et al., 2010). For patients with an MDE, early diagnosis and appropriate
treatment of BD are critical to improve the course and prognosis of BD.
For early diagnosis and appropriate treatment of BD in patients
with an MDE, it may be beneﬁcial to identify predictive factors of
BD at the initial visit, even if information regarding previous
manic/hypomanic episodes is not clear or is absent. The presence
of such predictors speciﬁc to BD facilitates a further intensive
medical interview for the discovery of BD in future years and for
an accurate diagnosis. Speciﬁc predictors correlated with BD have
been reported by multivariate logistic regression analyses (Angst
et al., 2011; Perlis et al., 2006; Takeshima and Oka, 2013; Xiang
et al., 2013). The common predictors correlated with BD are family
history of BD (Angst et al., 2011; Perlis et al., 2006; Takeshima and
Oka, 2013), early onset of an MDE (Angst et al., 2011; Perlis et al.,
2006; Takeshima and Oka, 2013; Xiang et al., 2013), and history of
multiple MDEs (Angst et al., 2011; Perlis et al., 2006; Takeshima
and Oka, 2013; Xiang et al., 2013). Generally, the candidate
predictors in these studies are listed as predictors reported in
earlier literatures (Angst et al., 2011; Takeshima and Oka, 2013). To
our knowledge, there has been no study that performed multi-
variate logistic regression analyses of candidate predictors selected
from a comprehensive record of several demographic and clinical
features that are not limited to commonly accepted theories. In
addition, previous studies (Angst et al., 2011; Perlis et al., 2006;
Takeshima and Oka, 2013; Xiang et al., 2013) did not examine
quality of life (QOL) or child abuse, both of which have been
recently identiﬁed as factors associated with the onset or clinical
course of BD (Daruy-Filho et al., 2011; Etain et al., 2008).
The present study was conducted in a variety of medical
facilities among patients with an MDE. This study aimed to
determine the prevalence of BD in patients with an MDE and to
identify predictors to support the diagnosis of BD using a com-
prehensive record of 74 demographic and clinical features that are
not limited to commonly accepted theories. To identify patients
with a high probability of BD among patients with an MDE, the
predictive performance of combinations of these factors that are
assessable at the initial visit was evaluated.
2. Subjects and methods
2.1. Study design and subjects
The Japanese epidemiological trial with the latest measure of
bipolar disorder (JET-LMBP) was a multicenter, cross-sectional, epi-
demiological study conducted from April to June 2013 at 23 psychia-
tric facilities in Japan: 2 university hospitals, 3 general hospitals,
3 psychiatric hospitals, and 15 psychiatric clinics. Outpatients aged 20
to 65 years who presented with an MDE according to the DSM-IV-TR
were included in the study (American Psychiatric Association, 2000).
The following patients were excluded: those diagnosed with “schizo-
phrenia and other psychotic disorders”, “mood disorder due to a
general medical condition”, and “substance-induced mood disorder”
according to the DSM-IV-TR; those at a high risk of an imminent
suicide attempt (in the judgment of the investigator); and those who
were determined to be unsuited to participate in the study by the
investigator.
2.2. Study procedures
Written informed consent was obtained from patients who met
all of the inclusion criteria and none of the exclusion criteria. After
informed consent was obtained, eligible patients were interviewed
using the M.I.N.I. to determine the presence of mood episodes and
psychiatric comorbidities such as anxiety disorder and substance-
related disorder (Otsubo et al., 2005; Sheehan et al., 1998). Mixed
depression was deﬁned as three or more positive items of D1b,
D2b and D3a–g with respect to the present MDE in the D module
(manic/hypomanic symptoms) of the M.I.N.I. according to Benaz-
zi's deﬁnition (Benazzi, 2007). The method of the M.I.N.I. was
modiﬁed in this study, D3a–g were asked regardless of the pre-
sence or absence of D1 and D2. In addition, various demographic
and clinical characteristics were assessed using a patient back-
ground sheet. The patient background sheet consisted of 52 ques-
tions that included basic patient information such as age, sex,
family history, features such as age of onset and number of epis-
odes, and current symptoms such as mood reactivity, hypersomnia
and excessive eating.
In addition, the patients were asked to complete three self-
reported questionnaires: the 16-item Japanese version of the Quick
Inventory of Depressive Symptomatology-Self Report (QIDS-SR-J),
which is designed to assess the severity of depression (Fujisawa
et al., 2010); the Japanese version of the 36-item Short-Form Health
Survey (SF-36), which is designed to assess the health-related QOL
(Fukuhara et al., 1998); and the Japanese version of the 38-item
Child Abuse and Trauma Scale (CATS) (ver. 5.0.J.), which is designed
to assess how frequently a particular abusive experience occurred
during the subject's childhood and adolescence (Nakai et al., 2014;
Sanders and Becker-Lausen, 1995; Tanabe et al., 2010). Based on the
collected information and routine clinical interviews, the investi-
gator made a principal diagnosis according to the DSM-IV-TR.
2.3. Statistical analysis
The SAS version 9.3 (SAS Institute Inc., Cary, NC, USA) was used for
the analyses. In all statistical analyses, a two-sided signiﬁcance level
of 5% was used. The Fisher's exact test or Wilcoxon test was used to
compare demographic characteristics between patients with BD and
those with MDD.
To identify predictors correlated with BD, univariate logistic
regression analyses were ﬁrst performed for the demographic and
clinical features of patients diagnosed with BD and those diag-
nosed with MDD. For the features with a p value of less than 0.001
and an odd ratio of 2 or more in the univariate logistic regression
analyses, a multivariate logistic regression analysis was performed.
The predictors with a p value of 0.05 or less in the multivariate
analysis were identiﬁed to be signiﬁcantly correlated with BD.
Finally, the predictive performance of the logistic regression
equation and the combinations of the factors correlated with BD
obtained by a multivariate logistic regression analysis was eval-
uated by a receiver-operating characteristic (ROC) curve analysis
based on the logistic regression equation or the number of the
predictors. In addition, the predictive performance of the logistic
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regression equation and the combinations of the factors that were
assessable at the initial visit was also evaluated by the ROC curve
analysis. A maximal Youden Index (sensitivity þspeciﬁcity-1) was
calculated and determined an optimal cut-off point for the number
of predictors (Akobeng, 2007).
2.4. Ethics
This study was conducted in accordance with the Declaration of
Helsinki and the Japanese Ethical Guidelines for Epidemiological
Research. Prior to the initiation of the study, the study protocol
was reviewed and approved by the institutional review board or
the ethics committee of each facility. Prior to any study proce-
dures, written informed consent was obtained from all patients. To
protect personal information of the patients, a study-speciﬁc uni-
que subject identiﬁcation number was assigned to each patient for
linkable anonymity.
3. Results
3.1. Number of patients
Four hundred seventy-one patients were enrolled in this study.
Of the 471 patients, 448 patients were included for analysis, excl-
uding 1 patient who failed to register on time, 21 patients who
failed to meet any of the inclusion criteria, and 1 patient who met
the exclusion criteria. Of the 448 patients, 31 patients (6.9%) were
from 5 university and general hospitals, 26 patients (5.8%) from
3 psychiatric hospitals, and 391 patients (87.3%) from 15 psychia-
tric clinics.
3.2. Prevalence of BD in patients with an MDE
Of the 448 patients with an MDE, 114 patients (25.4%) were given
a DSM-IV-TR diagnosis of BD (Fig. 1). Of the 114 patients, 42 patients
(9.4%) were diagnosed with bipolar I disorder (BD-I), 65 patients
(14.5%) with bipolar II disorder (BD-II), and 7 patients (1.6%) with
bipolar disorder not otherwise speciﬁed (BD-NOS). On the other hand,
the remaining 334 patients (74.6%) were diagnosed with MDD acco-
rding to the DSM-IV-TR, including 144 patients (32.1%) with MDD
single episode (sMDD) and 190 patients (42.4%) with MDD recurrent
(rMDD).
3.3. Patient characteristics
Demographic characteristics of patients diagnosed with BD
(N¼114) and those diagnosed with MDD (N¼334) are presented
in Table 1. The interval between the initial visit to the psychiatrist
and the ﬁrst diagnosis of BD was investigated in 97 patients with
BD. Twenty-four patients (24.7%) were diagnosed with BD within
1 year after the initial visit, 11 patients (11.3%) were diagnosed
between 1 and 2 years, 11 patients (11.3%) were diagnosed bet-
ween 2 and 3 years, 6 patients (6.2%) were diagnosed between
3 and 4 years, and 45 patients (46.4%) at 4 years or more. The
mean period was 4.6 years, and the median period was 3.0 years.
3.4. Predictors correlated with BD
After the patients were classiﬁed into those with BD and those
with MDD, univariate logistic regression analyses were performed
for 74 features (see Supplementary Table 1). Of the 74 features, 16
features with a p value of less than 0.001 and an odd ratio of 2 or
more were identiﬁed as candidate predictors correlated with BD.
When different candidate predictors were of the same nature, the
candidate predictor with the highest odd ratio was selected.
However, early age at the onset of an MDE (o25 years) (OR 2.75
[1.72–4.38]) was selected instead of early age at the onset of mood
episode (o25 years) (OR 4.68 [2.95–7.41]) because the former was
determined to be more useful for the clinical differential diagnosis
of BD versus MDD regarding a predictor correlated with BD in
patients with no previous manic/hypomanic episode. Because
mood stabilizer therapy in present use or antipsychotic therapy
in present use is likely to be chosen for BD compared with MDD
according to major treatment guidelines, these two features were
excluded from the multivariate analysis. A multivariate logistic
regression analysis was performed for the remaining nine fea-
tures: antidepressant-related switch to mania/hypomania, mixed
depression, two or more previous mood episodes within the past
year, family history of BD in ﬁrst-degree relatives, early age at the
onset of an MDE [o25 years], a history of suicide attempts,
signiﬁcant weight gain or increase in appetite, pathological feel-
ings of guilt, and interpersonal rejection sensitivity.
In the multivariate logistic regression analysis, the following ﬁve
features were identiﬁed as predictors signiﬁcantly correlated with
BD: antidepressant-related switch to mania/hypomania, mixed
depression, two or more previous mood episodes within the past
year, early age at the onset of an MDE (o25 years), and a history of
suicide attempts (Table 2). Subsequently, the following multivariate
logistic regression equation was formulated using the ﬁve predic-
tors signiﬁcantly correlated with BD: logit (A)¼ ln (A/1–A)¼–
13.8944þ4.4309X1þ2.8928X2þ1.9817X3þ1.2766X4þ0.7949X5
(A: probability of predicting BD [0–1], X: yes [2], no [1], where X1
is antidepressant-related switch to mania/hypomania, X2 is mixed
depression, X3 is two or more previous mood episodes within the
past year, X4 is early age at the onset of an MDE [o25 years], and
BD-I, 9.4%
BD-II, 14.5%
BD-NOS, 1.6%
sMDD, 32.1%
rMDD, 42.4%
BD-I
BD-II
BD-NOS
sMDD
rMDD
Fig. 1. Prevalence of bipolar disorders (N¼114) and major depressive disorders
(N¼334) in patients with a major depressive episode. BD-I, Bipolar I disorder; BD-
II, Bipolar II disorder; BD-NOS, Bipolar disorder not otherwise speciﬁed; sMDD,
Major depressive disorder, single episode; rMDD; Major depressive disorder,
recurrent.
Table 1
Demographic characteristics of bipolar disorder and major depressive disorder in
patients with a major depressive episode.
Characteristics BD
(N¼114)
MDD
(N¼334)
p
valuen
Sex (male), N (%) 48 (42.1) 139 (41.7) 1.000
Age (years), mean7SD 37.9710.3 40.1710.4 0.070
History of marriage, N (%) 63 (55.8) 173 (52.1) 0.515
History of divorce, N (%) 24 (21.1) 64 (19.3) 0.684
History of spouse's death, N (%) 4 (3.5) 9 (2.7) 0.747
Presence of spouse, N (%) 43 (37.7) 116 (34.8) 0.573
Presence of child, N (%) 46 (40.4) 145 (43.5) 0.584
Presence of housemate, N (%) 87 (76.3) 237 (71.4) 0.332
Duration of education (years),
mean7SD
13.872.5 13.572.4 0.303
Employment history, N (%) 69 (60.5) 213 (64.0) 0.574
History of job turnover, N (%) 71 (62.8) 200 (60.6) 0.738
BD, bipolar disorder; MDD, major depressive disorder
n The Fisher's exact test or Wilcoxon test was used.
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X5 is history of suicide attempts). An ROC curve constructed
according to the regression equation is shown in Fig. 2. When
the cut-off value of A was 0.5, sensitivity was 64.1%, speciﬁcity was
91.2%, and accuracy was 84.9%. The area under the time curve
(AUC) was 0.849.
Of the ﬁve predictors (i.e., antidepressant-related switch to
mania/hypomania, mixed depression, two or more previous mood
episodes within the past year, early age at the onset of an MDE (o25
years), and history of suicide attempts) signiﬁcantly correlated with
BD, the three predictors that were assessable at the initial visit were
included in the second multivariate logistic regression equation. logit
(A')¼ ln (A'/1–A') ¼ 6.7066 þ 2.6779X1 þ 0.9407X2 þ 1.1537X3
(A': probability of predicting BD [0–1], X: yes [2], no [1], where X1 is
mixed depression, X2 is early age at the onset of an MDE [o25
years], and X3 is history of suicide attempts). When the cut-off value
of A' was 0.5, sensitivity was 57.0%, speciﬁcity was 83.5%, and
accuracy was 76.6%. The AUC was 0.755.
The predictive performance of combinations of the ﬁve factors
(i.e., antidepressant-related switch to mania/hypomania, mixed
depression, two or more previous mood episodes within the past
year, early age at the onset of an MDE (o25 years), and history of
suicide attempts) signiﬁcantly correlated with BD that were
identiﬁed by the multivariate logistic regression analysis was
evaluated for BD versus MDD by the ROC curve analysis. The
sensitivity and speciﬁcity were 84.5% and 68.1% in the presence of
any one or more predictor, respectively; 41.7% and 94.1% in the
presence of any two or more predictors, respectively; 20.4% and
100% in the presence of any three or more predictors, respectively;
4.9% and 100% in the presence of any four or more predictors,
respectively; 1.9% and 100% in the presence of ﬁve predictors,
respectively. The AUC was 0.811. The optimal cut-off was in the
presence of any one or more predictor (sensitivity 84.5%, speciﬁ-
city 68.1%).
In addition, the predictive performance of combinations of the
three factors ( i.e., mixed depression, early age at the onset of an
MDE (o25 years), and history of suicide attempts) signiﬁcantly
correlated with BD that were assessable at the initial visit was
evaluated for BD versus MDD by the ROC curve analysis. The
sensitivity and speciﬁcity were 71.9% and 68.6% in the presence of
any one or more predictor, respectively; 29.8% and 95.0% in the
presence of any two or more predictors, respectively; 7.0% and
100% in the presence of three predictors, respectively. The AUC
was 0.733. The optimal cut-off was in the presence of any one
predictor (sensitivity 71.9%, speciﬁcity 68.6%).
4. Discussion
This study is the ﬁrst Japanese multicenter epidemiological study
of BD prevalence in patients with an MDE. The prevalence of BD in
patients with an MDE was 25.4%. In the Bipolar Disorders: Improving
Diagnosis, Guidance and Education (BRIDGE) study of 5635 patients
with an MDE, the prevalence of BD was 16.0%, though it varied
greatly from country to country (the lowest being 7.1% in South Korea
and the highest being 28.8% in Vietnam) (Angst et al., 2011). The
prevalence in the present study was within this range and not
substantially different from that of the BRIDGE study.
According to an earlier report, at least 5 years elapsed from the
initial treatment to the time that an accurate diagnosis of BD was
made in 51% of the patients with BD (Hirschfeld et al., 2003).
Another report indicated that 9.6 years, on average, elapsed from
the ﬁrst major mood episode to the initiation of appropriate
treatment of BD using a mood stabilizer (Drancourt et al., 2013),
highlighting the problem associated with the delay of both the
diagnosis and the appropriate treatment of BD in other countries.
The present study also investigated the interval between the initial
visit to the psychiatric facility and the ﬁrst diagnosis of BD. While
24.7% of the patients with BD were correctly diagnosed as BD
within 1 year after the initial visit, it took at least 4 years from the
initial visit to establish a BD diagnosis in 46.4% of those with BD.
Unrecognized BD treated as MDD may be associated with this
delayed BD diagnosis, as mentioned in the Introduction. Accord-
ingly, careful and intensive interviews designed to identify pre-
vious manic/hypomanic episodes may partly resolve the issue of
unrecognized BD. The identiﬁcation of demographic and clinical
predictors speciﬁc to BD, other than the presence of previous
manic/hypomanic episodes, is also helpful in resolving unrecog-
nized BD as MDD because the onset episode in two-thirds of the
patients with BD is a depressive episode (Daban et al., 2006).
Table 2
The results of multivariate logistic regression analysis of demographic and clinical features for bipolar disorder versus major depressive disorder.
Variable p value Odd ratio 95% CI
Antidepressant-related switch to mania/hypomania o0.001 79.308 16.530–380.496
Mixed depression o0.001 17.885 7.074–45.219
Two or more previous mood episodes within the past year 0.003 5.941 1.814–19.460
Early age at the onset of major depressive episode (o25 years) o0.001 3.600 1.837–7.058
Family history of bipolar disorder in ﬁrst-degree relatives 0.061 2.415 0.959–6.080
History of suicide attempts 0.041 2.128 1.033–4.386
Interpersonal rejection sensitivity 0.092 1.729 0.915–3.267
Signiﬁcant weight gain or increase in appetite 0.223 1.684 0.728–3.897
Pathological guilt feelings 0.112 0.551 0.264–1.150
95% CI, 95% conﬁdence intervals.
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Fig. 2. Receiver-Operation Characteristic (ROC) curve according to the logistic
regression equation using the ﬁve predictors correlated with bipolar disorders.
Five predictors: antidepressant-related switch to mania/hypomania, mixed depres-
sion, two or more previous mood episodes within the past year, early age at the
onset of MDE (o25 years), and a history of suicide attempts.
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Hence, the ﬁve clinical predictors signiﬁcantly correlated with BD
that were identiﬁed by the multivariate logistic regression analysis
are expected to contribute to early diagnosis and appropriate tre-
atment of BD in patients with an MDE. These ﬁve predictors inc-
lude antidepressant-related switch to mania/hypomania, mixed
depression, two or more previous mood episodes within the past
year, early age at the onset of an MDE (o25 years), and history of
suicide attempts (Table 2)
Two of the ﬁve predictors signiﬁcantly correlated with BD
identiﬁed in this study were also identiﬁed using multivariate logistic
regression analysis in several other studies (Angst et al., 2011; Perlis
et al., 2006; Takeshima and Oka, 2013; Xiang et al., 2013). They were
two or more previous mood episodes within the past year and early
age at the onset of an MDE (o25 years). Table 3 shows signiﬁcant
predictors correlated with bipolar disorder identiﬁed by multivariate
logistic regression analysis in four previous studies and in the present
study. These two predictors have also been proposed to be elements
of bipolarity by Ghaemi et al. (Ghaemi et al., 2001). Accordingly, we
can conclude that these predictors are relatively speciﬁc to BD among
patients with an MDE, including unrecognized BD. However, a
longitudinal study is necessary for the veriﬁcation of the predictive
value of these features for BD.
Mixed depression is important given that the present study and
two previous studies have identiﬁed the value of this predictor for BD
by the multivariate logistic regression analysis (Table 3) (Angst et al.,
2011; Takeshima and Oka, 2013). Consistent with this ﬁnding, Benazzi
have noted that compared with non-mixed depression, mixed depres-
sion, similar to mixed depression deﬁned in this study, is more
common in BD and is associated more strongly with a family history
of bipolar disorder, lower age at onset, longer duration, worse
outcome, and poorer response to antidepressant treatments
(Benazzi, 2007). Two other studies presented in Table 3 did not
examine mixed depression or did not include this predictor in the
multivariate logistic regression analysis perhaps because the standard
procedures in a DSM-IV-TR diagnosis and the M.I.N.I. cannot check
mixed depression (American Psychiatric Association, 2000; Perlis et al.,
2006; Sheehan et al., 1998; Xiang et al., 2013). In this study, we
modiﬁed the method of the M.I.N.I. to enable the detection of mixed
depression, as mentioned in Section 2, i.e., all items of the D module
(manic/hypomanic symptoms) were asked of all subjects by all means
regardless of the presence or absence of the ﬁrst or second items (D1
or D2). Recently, the DSM-5 included mixed features in the diagnostic
criteria, but the DSM-5-deﬁned mixed features of an MDE are
reportedly far less sensitive than Benazzi's mixed depression, which
is similar to our deﬁnition of mixed depression (American Psychiatric
Association, 2013; Takeshima and Oka, 2014). Koukopoulos reported
diagnostic criteria for mixed depression including agitation, irritability
and mood lability (Sani et al., 2014). In the future, the development
and validation of the diagnostic approach with mixed depression are
necessary for the application of this predictor to the auxiliary
diagnosis of BD.
Antidepressant-related switch to mania/hypomania was the
BD-correlated factor with the highest odd ratio in the present
study (Table 2). This predictor has also been proposed to be one of
the elements of bipolarity by Ghaemi et al. (Ghaemi et al., 2001).
The BRIDGE study, however, indicated that mania/hypomania with
an antidepressant was signiﬁcantly correlated with bipolarity that
met their original bipolarity speciﬁer criteria, which included
much broader pathological conditions than bipolar disorder acc-
ording to the DSM-IV-TR. However, it was not correlated with BD
Table 3
Predictors signiﬁcantly correlated with bipolar disorder in multivariate logistic regression analyses in the present study and other 4 previous studies.
Present study
2014
Xiang et al., 2013 Takeshima
and Oka, 2013
Angst et al., 2011 Perlis et al., 2006
Number of subjects 448 patients with
MDE
1487 patients with the
diagnosis of MDD
199 patients
with MDE
5635 patients with
MDE
1551 patients with MDE
Prevalence of BD 25.4% (BD-I, BD-II,
BD-NOS)
7.9% (BD-I) 40.2% (BP-II,
BP-NOS)
16.0% (BD-I, BD-II) 30.8% (BD-I)
12.8% (BD-II)
Mean duration of illness in
MDD (year)
5.7 5.9 not reported not reported 11.2 and 13.1
Number of mood episodes two or more
previous mood
episodes within
the past year
more life time
depressive episodes
(BD-I)
recurrent
MDEs(43)
Z2 prior mood
episode
a great previous number of depressive episode
Age of onset early age at the
onset of MDE
o25 years
earlier age of onset
(BD-I & II)
early age at
onset of ﬁrst
MDE (o25
years)
age at ﬁrst
psychiatric
symptoms o30
years
an earlier age at onset
Family history of BD n.s.n n.t. family history
of BDs in ﬁrst-
degree
relatives
hypomania/mania in
ﬁrst-degree relatives
family history of BD
Mixed depression mixed depression n.t. depressive
mixed state
current mixed state n.t.
Manic switch or lability with
antidepressant
antidepressant-
related switch to
mania/hypomania
n.t. n.s.n mood lability with
antidepressant
n.t.
History of suicide attempt history of suicide
attempt
n.s.n n.t. n.s. n.t.
Others more psychotic
symptoms (BD-I & II),
atypical depressive
features (BD-I)
cyclothymic
temperament
current depressive
episode r1 month,
current psychotic
features
eight individual symptom items on MADRS and
HAM-A (fears, sadness, insomnia, intellectual
[cognitive], somatic [muscular], respiratory,
genitourinary complaints and depressed behavior)
BD-I, bipolar I disorder; BD-II, bipolar II disorder; BD-NOS, bipolar disorder not otherwise speciﬁed; MDD, major depressive disorder; MDE, major depressive episode;
MADRS, Montgomery-Åsberg Depression Rating Scale; HAM-A, Hamilton Anxiety Rating Scale; n.t., not tested in multivariate analysis; n.s. not signiﬁcant in multivariate
analysis.
n signiﬁcant in univariate analysis.
T. Inoue et al. / Journal of Affective Disorders 174 (2015) 535–541 539
when compared with MDD (Angst et al., 2011). The BRIDGE study
showed the signiﬁcant relationship between mood liability with
an antidepressant, which was also correlated with BD in the
present study (see Supplementary Table 1), and BD/bipolarity
speciﬁed criteria. It is not clear why our results regarding mania/
hypomania with an antidepressant are not consistent with the
results of the BRIDGE study. However, their diagnostic principle
that the development of hypomania during antidepressant treat-
ment precludes a DSM-IV-TR diagnosis of BD may result in fewer
diagnoses of mania/hypomania with antidepressant in BD, alth-
ough according to the DSM-IV-TR, mania/hypomania with anti-
depressant treatment can be regarded as a manic/hypomanic
episode of BD when the symptoms are not due to the direct
physiological effects of antidepressants (American Psychiatric
Association, 2000). Takeshima and Oka (2013) reported that
antidepressant-induced mania/hypomania is signiﬁcantly more
prevalent in BD than in MDD using the univariate analysis, but
this ﬁnding was not conﬁrmed in the multivariate analysis, though
it did approach signiﬁcance (p¼0.056) (Table 3). Two additional
studies did not test the predictive ability of antidepressant-related
mania/hypomania for BD versus MDD (Table 3) (Perlis et al., 2006;
Xiang et al., 2013).
History of suicide attempts was identiﬁed as a correlated pre-
dictor of BD in the present study. However, in two earlier studies
(Angst et al., 2011; Xiang et al., 2013), a history of suicide attempts
was not a predictor correlated with BD in multivariate logistic
regression analyses although one study showed that a history of
suicidal ideation and/or attempts were more prevalent in BD than in
MDD (Table 3) (Xiang et al., 2013). History of suicide attempts
was not tested in two other studies (Table 3) (Perlis et al., 2006;
Takeshima and Oka, 2013). A correlation between BD and suicide-
related events has been reported by several studies. Previous studies
have found a signiﬁcantly higher percentage of patients with BD had
a history of suicide attempts (Bottlender et al., 2000) and suicidal
thoughts (Perlis et al.,2006) compared with patients with MDD.
Furthermore, the suicide rate is higher in patients with BD than in
those with MDD or other mental disorders (Nordentoft et al., 2011).
These ﬁndings may support the results of our study. In addition,
another report found that the percentage of patients with a history of
suicide attempts signiﬁcantly increased when the initiation of
appropriate therapeutic intervention was delayed (Altamura et al.,
2010). Thus, early diagnosis of BD may help prevent suicide attempts
and suicides.
In earlier studies, the family history of BD in ﬁrst-degree relatives
was one of the factors correlated with BD (Table 3) (Angst et al., 2011;
Perlis et al., 2006; Takeshima and Oka, 2013). While the p value of
family history of BD in ﬁrst-degree relatives was o0.001 according
to the univariate regression analysis in the present study, it was 0.061
using the multivariate regression analysis. Compared with other
studies, the relatively small sample size of the present study may
account for the negative result in the multivariate regression analysis.
Another possibility of the inconsistency of the results between the
present study and earlier studies is that the duration of illness in
MDD patients in our study (average 5.7 years) was relatively shorter
than that of the other studies, which was reportedly 11.2 or 13.1 years
in one study (Perlis et al., 2006) and was not reported in two
previous studies (Angst et al., 2011; Takeshima and Oka, 2013). A
shorter duration of MDD from the onset of the ﬁrst episode may fail
to reveal unrecognized bipolar disorder in a portion of MDD patients
as unipolar-to-bipolar conversion in most BD patients with depres-
sive onset occurs within 5–9 years (Akiskal et al., 1995).
The present study showed that one or more predictor cannot
predict a diagnosis of BD with high speciﬁcity because it has an
84.5% degree of sensitivity and a 68.1% degree of speciﬁcity, thus
suggesting that one or more predictor might be suitable for scre-
ening purposes but not for diagnostic purposes. Combinations of
two or more predictors, which exhibited a 41.7% degree of sen-
sitivity and a 94.1% degree of speciﬁcity, are necessary for BD
diagnostic purposes. This is consistent with the results of a
previous study (Takeshima and Oka, 2013).
The major limitation of the present study was to investigate the
predictors for BD in patients, the diagnosis of which was already
conclusively conﬁrmed by long illness observations. An earlier long-
term prospective study using Cox proportional hazards regression
reported that mixed depression, psychotic features of an MDE, and
early age of onset predict the progression from MDD to BD
(Fiedorowicz et al., 2011). In addition, another long-term prospective
case-control study showed that early age of onset, family history of
BD, antidepressant-associated hypomania, and hypersomnic-retarded
phenomenology are useful in predicting transformation from MDD to
BD (Akiskal et al., 1983). These ﬁndings are broadly consistent with
the present study. In future studies, the predictive value of ﬁve
features speciﬁc to BD identiﬁed by the present study should be conf-
irmed in unrecognized BD by a large long-term prospective study.
In conclusion, the present study identiﬁed ﬁve predictors corre-
lated with BD in patients with an MDE from 74 potential demo-
graphic and clinical features that were not limited to commonly acc-
epted theories. These predictors are consistent with previously rep-
orted factors used to predict BD. Furthermore, the ROC curve analysis
indicated that the logistic regression equation and the combination
of the ﬁve predictors or three predictors that are assessable at the
initial visits can facilitate the differential diagnosis of BD and MDD
and can be easily applied in clinical settings.
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